FDA Inspection 1200268 — COSMOBEAUTI LABORATORIES & MANUFACTURING, INC.

COSMOBEAUTI LABORATORIES & MANUFACTURING, INC. — FEI 3003921470

The FDA completed an inspection of COSMOBEAUTI LABORATORIES & MANUFACTURING, INC. on March 15, 2023 in San Dimas, CA. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). 8 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
March 15, 2023
Fiscal Year
2023
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
San Dimas, CA (United States)

Citations

IDCFRDescription
110521 CFR 211.22(d)Procedures not in writing, fully followed
180121 CFR 211.84(a)Components withheld from use pending release
191421 CFR 211.166(a)Lack of written stability program
200921 CFR 211.188Prepared for each batch, include complete information
202621 CFR 211.192Quality control unit review of records
202721 CFR 211.192Investigations of discrepancies, failures
355921 CFR 211.56(a)Sanitation--buildings not clean, free of infestation
358521 CFR 211.110(a)Control procedures to monitor and validate performance